USD 9.59 billion
Regenerative Medicine Market Size, Share, Growth Analysis, By Product Type(Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic), By Material(Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical), By Application(Cardiovascular, Oncology, Dermatology, Musculoskeletal), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2129 |
Region:
Global |
Published Date: August, 2024
Pages:
157
|Tables:
92
|Figures:
76
Regenerative Medicine Market Insights
Global Regenerative Medicine Market size was valued at USD 9.59 Billion in 2022 poised to grow from USD 12.2 Billion in 2023 to USD 83.6 Billion by 2031, growing at a CAGR of 27.2% in the forecast period (2024-2031).
The multidisciplinary field of regenerative medicine aims to use the body's innate healing powers to replace, regenerate or repair damaged tissues and organs. This is accomplished through tissue regeneration and restoration of normal function using stem cells, tissue engineering, growth factors, and biomaterials. There are many benefits associated with regenerative medicine including its capacity to allow for individualized treatments for various medical conditions like congenital defects, massive injuries, and degenerative disorders. Regenerative medicine holds forth the possibility of better results, less dependency on traditional therapies like organ transplantation, and an improvement in patients' quality of life through encouraging tissue repair and regeneration.
The growth of the burgeoning regenerative medicine industry can be greatly attributed to the escalating demand for personalized treatment. Personalized medicine is an approach in which medical care is tailored for patients’ individual characteristics such as genetic makeup, lifestyle or environment. Regenerative medicines fit well into personalized medicine since both rely on technologies like gene editing and stem cell therapy to achieve individualized treatment. As patients search for treatments that work more efficiently, cause lesser side effects and cater to their personal preferences, regenerative therapies are increasingly in demand. It is also expected that the market will grow faster in the upcoming years due to the expanding use of stem cell technologies, as well as the rising number of product launches and approvals globally.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Therapeutics
Fastest Growth
Therapeutics
Growth Rate
27.2% CAGR
Global Regenerative Medicine Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Regenerative Medicine Market Segmental Analysis
The Global Regenerative Medicine Market is segmented based on Product Type, Material and Application. In terms of Product Type, the market is grouped into Cell Therapy, Gene Therapy, Tissue Engineering and Small Molecule & Biologic. Based on the Material, the market is segmented into Synthetic Material, Biologically Derived Material, Genetically Engineered Material and Pharmaceutical. In terms of Application, the market is grouped into Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology and Others. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and Middle East & Africa.
Analysis by Product Type
As per categorization by product type, the market is classified as cell therapy, gene therapy, tissue engineering and small molecule & biologic. Among these, cell therapy earned the largest share and continues to dominate the market. The ability of cell therapy to repair damaged tissues and heal chronic illnesses is propelling innovation in the global regenerative medicine market. The reason it rules the market is that it provides individualized, efficient care, especially in fields where traditional medications are not very successful, including oncology and cardiovascular disorders.
Tissue engineering is anticipated to increase the fastest in the global regenerative medicine market due to its ability to create organs and tissues that work. This will alleviate the shortage of organs. Its use in regenerative treatments for complex wounds and diseases is hastening due to progressions in biomaterials and 3D printing technology.
Analysis by Application
With the innovations in stem cell therapy and biomaterials that support tissue rehabilitation and development, regenerative medicine sees many applications in the musculoskeletal area making it the largest market globally. Moreover, these medications are increasingly being used for the management of degenerative diseases like arthritis as well as injuries since they provide better outcomes than conventional treatments alongside having a huge room for growth within this field.
Advances in cell treatments and immunotherapies that target cancer at the cellular level are expected to make oncology the application in the global regenerative medicine market that grows at the highest rate. The need for cutting-edge cancer therapy is increasing, and these novel treatments are meeting that demand quickly by providing more effective, personalized solutions.
Global Regenerative Medicine Market By Product
To get detailed analysis on other segments, Request For Free Sample Report
Regenerative Medicine Market Regional Insights
North America is the leader in the global regenerative medicine market due to its strong biotechnology investments, extensive infrastructure for research and development, and concentration of important industry participants. The favorable regulatory frameworks, such as the fast approval processes offered by the FDA, support the region's leadership in innovative medicines, including gene and cell therapies. Additionally, this industry is due to climbing price tags being imposed on medical services or rather the increasing demand for new ways of treatment regarding degenerative and chronic ailments. To hasten the pace of innovation and position North America as a global leader in promoting and commercializing regenerative therapeutic options, academic institutions are collaborating with biopharma companies.
The Asia-Pacific region has the fastest pace in terms of worldwide regeneration medicine market expansion due to its rapidly improving health care system, increased investments in biotechnology, and supportive government policies. Such countries like South Korea, China, Japan and others have big chronic illness rates, huge numbers of patients requiring advanced treatment and well-established research capabilities. Additionally, the growth of the industry is also fueled by positive regulatory frameworks such as those in Japan that accelerate the approval process for regenerative therapies. Due to its expertise in clinical trials and economical manufacturing, the region attracts global biopharmaceutical companies which promote innovation and boost access to regenerative medicine options.
Global Regenerative Medicine Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Regenerative Medicine Market Dynamics
Drivers
Focusing on Personalized Medicine First
- Precision medicine is a medical treatment method that customizes therapies and interventions for specific patients or a subgroup according to their genetic, environmental, and lifestyle factors. Treatments for uncommon genetic disorders that have few other options include haemophilia B, cerebral adrenoleukodystrophy, beta thalassaemia, refractory multiple myeloma, and some forms of non-muscle invasive bladder cancer.
Taking Advantage of 3D Printing's Potential
- Technological developments are critical to the tissue engineering market's expansion since they encourage creativity and broaden the field's application base. Researchers and engineers have been able to create complex tissue-engineered products with improved functions due to the ongoing advancements in materials science, bioengineering methods, and imaging technology.
Restraints
Concerns about Ethics, Law, and the Expensive Price of Regenerative Medicine
- Since stem cells are produced by destroying human embryos, there are ethical concerns with their use. Even if it can save a human life, it is unethical to destroy a human embryo as it is thought of as a potential life. These worries about using embryonic stem cells to produce stem cell treatment are some of the things impeding the worldwide market's expansion.
Inadequate Reimbursement Regulations in Different Areas
- A major obstacle to the global market's growth trajectory is the absence of inadequacy of reimbursement policies. The impediment towards regenerative therapies is both for patients and health care practitioners, given the fact that reimbursement mechanisms are not so well defined. There are various payment systems which are complex and unevenly spread out across different geographical locations; this prevents widespread adoption of these latest drugs. This aspect is likely to slow down growth in the case of a market.
Request Free Customization of this report to help us to meet your business objectives.
Regenerative Medicine Market Competitive Landscape
The global regenerative medicine market is extremely competitive worldwide, and the major competitors are strengthening their positions in the industry through partnerships, acquisitions, and innovation. At the belly of advances in stem cell research, tissue engineering, cell and gene therapy are prominent companies such as Novartis, Medtronic, Gilead Sciences and Mesoblast. By creating novel treatments using their considerable research and development capital and global expertise, these firms are redefining regenerative medicine while developing new drugs that can help them expand into new markets.
Top Player’s Company Profiles
- Novartis AG (Switzerland)
- Biogen, Inc. (USA)
- Sarepta Therapeutics, Inc. (USA)
- Gilead Sciences, Inc. (USA)
- Amgen Inc. (USA)
- Smith+Nephew (UK)
- MEDIPOST Co., Ltd. (Korea)
- JCR Pharmaceuticals Co., Ltd. (Japan)
- Takeda Pharmaceutical Company Limited (Japan)
- CORESTEM, Inc (South Korea).
- Zimmer Biomet Holdings Inc. (USA)
- AbbVie Inc. (USA)
- Cryolife, Inc (USA)
- Stryker (USA)
- Medtronic Plc (Ireland)
Recent Developments
- In March 2024, A final report released by Novartis concerning its new cell treatment for CAR-T confirmed that it has successfully undertaken a Phase II clinical trial targeting aggressive forms of lymphoma. It has been demonstrated by better patient outcomes and higher remission rates achieved by this trial that Novartis is a market leader in developing advanced cell therapies for regenerative medicine.
- In June 2024, The FDA has approved Gilead Sciences’ pioneering gene therapy aimed at treating a rare genetic condition that affects the cerebral system. This approval emphasizes Gilead’s commitment to developing innovative therapies for previously untreatable illnesses and marks a significant milestone in the company’s expansion into regenerative medicine.
- In July 2024, A new regenerative bone graft product from Medtronic was introduced with the goal of improving spinal fusion procedures. Using cutting-edge tissue engineering techniques, the product has demonstrated encouraging results in shortening recovery periods and speeding bone regeneration, establishing Medtronic as a leading pioneer in the orthopedic and regenerative medicine sectors.
Regenerative Medicine Key Market Trends
- Stem Cell Therapies Leading the Charge in the Evolving Regenerative Medicine Market: As scientific and technological advancements change the healthcare landscape; regenerative medicine has experienced noticeable trends in its market. The growing popularity of stem cell therapies is one such example. Regenerative medicine has stem cells that can turn into many different types of cells, bringing an optimistic feeling for tissue regrowth and fixing.
- CRISPR-Cas9 Revolutionizing Regenerative Medicine with Precision Genetic Interventions: The global regenerative medicine market is being impacted by the emergence of gene treatments. Due to gene editing techniques such as CRISPR-Cas9, it is now possible to make accurate modifications to genetic instructions, allowing for new treatment possibilities for hereditary disorders and a better power in regenerating impaired tissues. This presents a direction towards fixing primary hereditary defects and fostering tissue renewal, which would cultivate new therapeutics via genomic medicine approaches.
Regenerative Medicine Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, Finally, it should be noted that the development of personalized medicine, stem cell therapies, and gene editing tools like CRISPR-Cas9 is rapidly changing the global regenerative medicine market. These advancements are improving treatment options and curing diseases previously thought to be incurable, leading to better patient outcomes.
Growth in the market is driven by significant investments in biotechnology, favorable regulatory climates and an increasing demand for personalized therapy. However, to unlock the full potential of regenerative medicine, problems such as ethical questions, high prices and inadequate reimbursement policies must be addressed. As the sector evolves, leading firms must join forces to enhance access worldwide to these revolutionary treatments and ahead methods.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 9.59 Billion |
| Market size value in 2031 | USD 83.6 Billion |
| Growth Rate | 27.2% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Regenerative Medicine Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Regenerative Medicine Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Regenerative Medicine Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Regenerative Medicine Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Regenerative Medicine Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Regenerative Medicine Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
